Ticker Details
Aprea Therapeutics, Inc.
IPO Date:	September 30, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$11.76M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.32 | 3.90%
Avg Daily Range (30 D):	$0.05 | 5.56%
Avg Daily Range (90 D):	$0.04 | 5.28%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.29M
Avg Daily Volume (90 D):	1.65M

Trade Size
Avg Trade Size (Sh.):	236
Avg Trade Size (Sh.) (30 D):	332
Avg Trade Size (Sh.) (90 D):	432

Institutional Trades
Total Institutional Trades:	121
Avg Institutional Trade:	$1.73M
Avg Institutional Trade (30 D):	$.52M
Avg Institutional Trade (90 D):	$.52M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	7.56K

News

Jun 25, 2025 @ 1:00 PM Aprea Reports Anti-Proliferative Results and Promi... Source: N/A

May 14, 2025 @ 12:00 PM Aprea Therapeutics Reports First Quarter 2025 Fina... Source: N/A

Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics

Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics

May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.5	$-.22	$-.28
Diluted EPS	$-1.5	$-.22	$-.28
Revenue	$.12M	$M	$M
Gross Profit
Net Income / Loss	$-11.95M	$-3.29M	$-2.46M
Operating Income / Loss	$-12.58M	$-3.43M	$-2.64M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Feb 13, 2023	1:20
Dec 27, 2018	1:1000
Sep 13, 2011	1:500